1.
Sussman G, Hebert J, Gulliver W, Lynde C, Lang WH, Chambenoit O, Deutsch G, DeTakaosy F, Rihakova L. Design and Rationale of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU). J of Skin [Internet]. 2018Feb.23 [cited 2020Nov.29];2(S1):S51. Available from: https://jofskin.org/index.php/skin/article/view/296